Table 2.
Distribution (%) of cervical cancer screening results among women receiving their first Pap test in the National Breast and Cervical Cancer Early Detection Program by age and screening history, 2002–2012
| Screening history NR | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NR | P5Y | |||||||||||||||
| Total | 18–20 | 21–29 | 30–39 | 40–49 | 50–59 | 60–64 | 65+ | Total | 18–20 | 21–29 | 30–39 | 40–49 | 50–59 | 60–64 | 65+ | |
| Number of women with current Pap test | 461,893 | 7,866 | 28,489 | 41,878 | 173,820 | 159,036 | 44,549 | 6,255 | 1,023,358 | 11,890 | 69,523 | 108,966 | 414,599 | 325,157 | 84,537 | 8,686 |
| Cytology (%) | ||||||||||||||||
| Negative | 91.7 | 82.9 | 84.2 | 89.8 | 91.5 | 93.3 | 94.2 | 93.9 | 91.4 | 72.4 | 79.3 | 89.1 | 91.8 | 93.8 | 95.0 | 94.8 |
| ASC-US | 4.1 | 7.8 | 7.0 | 4.7 | 4.3 | 3.4 | 2.6 | 2.5 | 4.4 | 11.6 | 9.1 | 5.4 | 4.5 | 3.3 | 2.5 | 2.4 |
| LSIL | 1.7 | 7.4 | 6.1 | 2.5 | 1.5 | 1.0 | 0.6 | 0.6 | 2.0 | 12.4 | 7.9 | 2.9 | 1.6 | 1.0 | 0.7 | 0.5 |
| ASC-H | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.7 | 0.6 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 |
| HSIL | 0.8 | 1.0 | 1.3 | 1.3 | 0.9 | 0.6 | 0.5 | 0.8 | 0.6 | 2.1 | 2.0 | 1.1 | 0.5 | 0.3 | 0.3 | 0.5 |
| Squamous cell cancer | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Atypical glandular cells | 0.3 | 0.1 | 0.1 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.0 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 |
| Unsatisfactory | 0.8 | 0.4 | 0.7 | 0.7 | 0.8 | 0.9 | 1.1 | 1.3 | 0.8 | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 1.0 | 1.1 |
NR never or rarely (not screened within 5 years) screened, P5Y screened within 5 years, ASC-H atypical squamous cells of undetermined significance—cannot exclude HSIL, ASC-US atypical squamous cells of undetermined significance, HSIL high-grade squamous intraepithelial lesion, LSIL low-grade squamous intraepithelial lesion